«‹1234567»Seite
7 articles with references, page 1 of 7

Review article

Aneurysms of the Ascending Aorta

Dtsch Arztebl Int 2012; 109(13): 227-33; DOI: 10.3238/arztebl.2012.0227

Lavall, D; Schäfers, H; Böhm, M; Laufs, U

1. Hiratzka LF, Bakris GL, Beckman JA, et al.: 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease:
a report of the American College of Cardiology Foundation/
American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and
Interventions, Society of Interventional Radiology, Society of
Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121: e266–369. CrossRef MEDLINE
2. Elefteriades JA, Farkas EA: Thoracic aortic aneurysm clinically
pertinent controversies and uncertainties. J Am Coll Cardiol 2010; 55: 841–57. CrossRef MEDLINE
3. Lemaire SA, McDonald ML, Guo DC, et al.: Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat Genet 2011; 43: 996–1000. CrossRef MEDLINE PubMed Central
4. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd: Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med 2008; 358: 2787–95. CrossRef MEDLINE PubMed Central
5.Cozijnsen L, Braam RL, Waalewijn RA, et al.: What is new in dilatation of the ascending aorta? Review of current literature and practical advice for the cardiologist. Circulation 2011; 123: 924–8. CrossRef MEDLINE
6.Vahanian A, Baumgartner H, Bax J, et al.: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230–68. MEDLINE
7.Tadros TM, Klein MD, Shapira OM: Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation 2009; 119: 880–90. CrossRef MEDLINE
8.Judge DP, Dietz HC: Marfan’s syndrome. Lancet 2005; 366: 1965–76. CrossRef MEDLINE
9.Silverman DI, Burton KJ, Gray J, et al.: Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75: 157–60. CrossRef MEDLINE
10. Loeys BL, Schwarze U, Holm T, et al.: Aneurysm syndromes caused by mutations in the TGF-ß receptor. N Engl J Med 2006; 355: 788–98. CrossRef MEDLINE
11. Danyi P, Elefteriades JA, Jovin IS: Medical therapy of thoracic aortic aneurysms: are we there yet? Circulation 2011; 124: 1469–76. CrossRef MEDLINE
12. Erdheim J: Medionecrosis aortae idiopathica cystica. Virchows Archiv 1930; 76: 187–229. CrossRef
13. Aicher D, Urbich C, Zeiher A, Dimmeler S, Schäfers HJ: Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann Thorac Surg 2007; 83: 1290–4. CrossRef MEDLINE
14. Michelena HI, Khanna AD, Mahoney D, et al.: Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011; 306: 1104–12. CrossRef MEDLINE
15. Hope MD, Hope TA, Meadows AK, et al.: Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology 2010; 255: 53–61. CrossRef MEDLINE
16. Mookadam F, Thota VR, Garcia-Lopez AM, et al.: Unicuspid aortic valve in adults: a systematic review. J Heart Valve Dis 2010; 19: 79–85. MEDLINE
17. Matura LA, Ho VB, Rosing DR, Bondy CA: Aortic dilatation and dissection in Turner syndrome. Circulation 2007; 116: 1663–70. CrossRef MEDLINE
18. Tavora F, Burke A: Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu’s and giant cell aortitis. Pathology 2006; 38: 302–8. CrossRef MEDLINE
19.Masuda Y, Yamada Z, Morooka N, Watanabe S, Inagaki Y: Prognosis of patients with medically treated aortic dissection. Circulation 1991; 84: III7–13. MEDLINE
20. Gott VL, Greene PS, Alejo DE, et al.: Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med 1999; 340: 1307–13. CrossRef MEDLINE
21. Hannuksela M, Lundqvist S, Carlberg B: Thoracic aorta—dilated or not? Scand Cardiovasc J 2006; 40: 175–8. CrossRef MEDLINE
22. Svensson LG, Kim KH, Lytle BW, Cosgrove DM: Relationship of aortic cross-sectional area to height ratio and the risk of aortic dissection in patients with bicuspid aortic valves. J Thorac Cardiovasc Surg 2003; 126: 892–3. CrossRef MEDLINE
23. Svensson LG, Khitin L: Aortic cross-sectional area/height ratio timing of aortic surgery in asymptomatic patients with Marfan syndrome. J Thorac Cardiovasc Surg 2002; 123: 360–1. CrossRef MEDLINE
24. Roman MJ, Devereux RB, Kramer-Fox R, O’Loughlin J: Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507–12. CrossRef MEDLINE
25. Aicher D, Kunihara T, Abou Issa O, Brittner B, Graber S, Schäfers HJ: Valve configuration determines long-term results after repair of the bicuspid aortic valve. Circulation 2011; 123: 178–85. CrossRef MEDLINE
e1. National Center for Injury Prevention and Control: WISQARS leading causes of death reports, 1999–2006. Available at: http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html. Accessed on 08 March 2011.
e2. Clouse WD, Hallett JW Jr, Schaff HV, Gayari MM, Ilstrup DM, Melton LJ 3rd: Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998; 280: 1926–9. MEDLINE
e3. Booher AM, Eagle KA: Diagnosis and management issues in
thoracic aortic aneurysm. Am Heart J 2011; 162: 38–46. CrossRef MEDLINE
e4. Harris KM, Strauss CE, Eagle KA, et al.: Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation 2011; 124: 1911–8. MEDLINE
e5. Habashi JP, Judge DP, Holm TM, et al.: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117–21. MEDLINE
e6. Habashi JP, Doyle JJ, Holm TM, et al.: Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011; 332: 361–5. MEDLINE
e7. Roberts WC, Ko JM, Moore TR, Jones WH 3rd: Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 2006; 114: 422–9. CrossRef MEDLINE
e8. La Canna G, Maisano F, De Michele L, et al.: Determinants of the degree of functional aortic regurgitation in patients with anatomically normal aortic valve and ascending thoracic aorta aneurysm. Transoesophageal Doppler echocardiography study. Heart 2009; 95: 130–6. MEDLINE
e9. Guo DC, Papke CL, He R, Milewicz DM: Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 2006; 1085: 339–52. MEDLINE
e10. Ye S: Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006; 69: 636–45. CrossRef MEDLINE
e11. Arslan-Kirchner M, von Kodolitsch Y, Schmidtke J: The importance of genetic testing in the clinical management of patients with Marfan syndrome and related disorders. Dtsch Arztebl Int 2008; 105: 483–91. MEDLINE PubMed Central
e12. Loeys BL, Dietz HC, Braverman AC, et al.: The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476–85. MEDLINE
e13. Pepin M, Schwarze U, Superti-Furga A, Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673–80. MEDLINE
e14. Koullias G, Modak R, Tranquilli M, Korkolis DP, Barash P, Elefteriades JA: Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg 2005; 130: 677–83. MEDLINE
e15. Lee TC, Zhao YD, Courtman DW, Stewart DJ: Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000; 101: 2345–8. MEDLINE
e16. Brenner DJ, Hall EJ: Computed tomography--an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277–84. CrossRef MEDLINE
e17. Coady MA, Rizzo JA, Hammond GL, et al.: What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 1997; 113: 476–91. MEDLINE
e18. Sambola A, Tornos P, Ferreira-Gonzalez I, Evangelista A: Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation. Am Heart J 2008; 155: 1114–20. CrossRef MEDLINE
e19. Elefteriades JA: Beating a sudden killer. Sci Am 2005; 293: 64–71. MEDLINE
e20. Gazoni LM, Speir AM, Kron IL, Fonner E, Crosby IK: Elective thoracic aortic aneurysm surgery: better outcomes from high-volume centers. J Am Coll Surg 2010; 210: 855–9; discussion: 859–60. CrossRef MEDLINE
e21. Achneck HE, Rizzo JA, Tranquilli M, Elefteriades JA: Safety of thoracic aortic surgery in the present era. Ann Thorac Surg 2007; 84: 1180–5. MEDLINE
e22. Ehrlich MP, Ergin MA, McCullough JN, et al.: Predictors of adverse outcome and transient neurological dysfunction after ascending aorta/hemiarch replacement. Ann Thorac Surg 2000; 69: 1755–63. MEDLINE
e23. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH: Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36: 1152–8. CrossRef MEDLINE
e24. Huang G, Rahimtoola SH: Prosthetic heart valve. Circulation 2011; 123: 2602–5. MEDLINE
e25. Zehr KJ, Orszulak TA, Mullany CJ, et al.: Surgery for aneurysms of the aortic root: a 30-year experience. Circulation 2004; 110: 1364–71. MEDLINE
e26. Palmieri V, Bella JN, Arnett DK, et al.: Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study. Hypertension 2001; 37: 1229–35. MEDLINE